Fate Therapeutics Inc (FATE) returns
Fate Therapeutics returns over 10 years
$1,000 invested in Fate Therapeutics ten years ago was worth $954.13 at the close on October 30, 2026, with dividends reinvested: an average return of -0.5% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -12.2% | — | $877.64 | -0.9% |
| 3 months | -17.1% | — | $828.69 | +2.1% |
| Year to date | +111.7% | — | $2,117 | +11.7% |
| 1 year | +61.2% | — | $1,612 | +12.4% |
| 3 years | +20.2% | +6.3% | $1,202 | +88.5% |
| 5 years | -96.1% | -47.8% | $38.66 | +76.0% |
| 10 years | -4.6% | -0.5% | $954.13 | +316.6% |
Fate Therapeutics return by calendar year
| Year | FATE | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +111.7% | +11.7% | +100.0% |
| 2025 | -40.4% | +17.7% | -58.2% |
| 2024 | -55.9% | +24.9% | -80.8% |
| 2023 | -62.9% | +26.2% | -89.1% |
| 2022 | -82.8% | -18.2% | -64.6% |
| 2021 | -35.7% | +28.7% | -64.4% |
| 2020 | +364.6% | +18.4% | +346.3% |
| 2019 | +52.5% | +31.2% | +21.3% |
| 2018 | +110.0% | -4.6% | +114.5% |
| 2017 | +143.4% | +21.7% | +121.7% |
| 2016 | -25.5% | +12.0% | -37.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: FATE financials
No forecast, no recommendation. This page describes Fate Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.